Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

NCT01391962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Alveolar Soft Part

Interventions

DRUG: Cediranib
DRUG: Sunitinib
OTHER: Prochlorperazine
OTHER: Promethazine
OTHER: Benzodiazepine
OTHER: Filgrastim
OTHER: Sargramostim
OTHER: Lomotil
OTHER: Loperamide
OTHER: Vitamin B6
OTHER: Aquaphor
DRUG: Acetaminophen
DRUG: Levothyroxine
DRUG: Warfarin

Sponsor

National Cancer Institute (NCI)